HSP90B1 and neoplasm: Upregulation of GRP78 (85–88) and GRP94 (89–91), likely due to the adaptive UPR in cancer cells, have also been associated with the poor survival or recurrence in cancer patients as well as tumor resistance to radiotherapy.